CORRECTION OF PLATELET AGGREGATION ACTIVITY DISTURBANCES IN CHILDREN WITH  CHRONIC GLOMERULONEPHRITIS

YAXYAYEVA, K.Z.; KHURSANOVA, M.O; DONIYOROV, S.T.

dc.contributor.author	YAXYAYEVA, K.Z.
dc.contributor.author	KHURSANOVA, M.O
dc.contributor.author	DONIYOROV, S.T.
dc.date.accessioned	2023-05-26T04:49:48Z
dc.date.available	2023-05-26T04:49:48Z
dc.date.issued	2023-05-12
dc.identifier.issn	2181–5887
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/7930
dc.description.abstract	A comprehensive examination of 46 children aged 7 to 15 years old, who were hospitalized in the pediatric nephrology department of the TMA clinic (Tashkent medical academy) with a nephrotic form of chronic glomerulonephritis, was carried out. Of these, 22 children (group 1) received traditional therapy, 24 children (group 2) received dipyridamole at a dose of 3–4 mg/kg, 2 times a day as antiplatelet therapy. Indicators of platelet aggregation activity were studied on a “Chronolog–140” aggregometer (USA) in the biochemical laboratory of the RSCC (Republican Specialized Center for Cardiology) before treatment and after two weeks of dipyridamole therapy. The digital material was processed by the method of variation statistics.	en_US
dc.language.iso	en	en_US
dc.publisher	O‘ZBEKISTON TERAPIYA AXBOROTNOMASI Ilmiy-amaliy jurnal	en_US
dc.subject	To evaluate the effectiveness of the inclusion of dipyridamole in the correction of platelet aggregation disorders in children with nephrotic form of chronic glomerulonephritis.	en_US
dc.title	CORRECTION OF PLATELET AGGREGATION ACTIVITY DISTURBANCES IN CHILDREN WITH CHRONIC GLOMERULONEPHRITIS	en_US
dc.type	Thesis	en_US